The proof of concept of CRT was provided by the first randomized controlled study (RCT), the MUSTIC trial (Multisite Stimulation in Cardiomyopathies) in 2001. CARE-HF (Cardiac Resynchronization in ...
Read the Market Summary Here @- Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Booming at Healthy CAGR of 8.4% to Touch USD 11.6 Billion by 2030 Global Cardiac Resynchronization ...
Clinical trials have consistently shown improved outcome with CRT-defibrillators (CRT-D) and more trials have demonstrated the benefits of the defibrillator in the population with depressed LV ...
Indication* Europe (N = 85;%) Japan (N = 20;%) United States (N = 177;%) Total (N = 282;%) LVEF < = 35%, functional class III, regardless of heart failure etiology 65 ...